Medirom Healthcare Return On Equity vs. Price To Book
| MRM Stock | USD 1.05 0.04 3.67% |
Return On Equity | First Reported 2010-12-31 | Previous Quarter 0.54556879 | Current Value 0.57 | Quarterly Volatility 1.53720059 |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.26 | 0.2298 |
|
|
For Medirom Healthcare profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Medirom Healthcare to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Medirom Healthcare Technologies utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Medirom Healthcare's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Medirom Healthcare Technologies over time as well as its relative position and ranking within its peers.
Medirom |
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Medirom Healthcare. If investors know Medirom will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Medirom Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.582 | Earnings Share (0.15) | Revenue Per Share 1.4 K | Quarterly Revenue Growth (0.06) | Return On Assets (0.04) |
The market value of Medirom Healthcare is measured differently than its book value, which is the value of Medirom that is recorded on the company's balance sheet. Investors also form their own opinion of Medirom Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Medirom Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Medirom Healthcare's market value can be influenced by many factors that don't directly affect Medirom Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Medirom Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Medirom Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Medirom Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Medirom Healthcare Price To Book vs. Return On Equity Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Medirom Healthcare's current stock value. Our valuation model uses many indicators to compare Medirom Healthcare value to that of its competitors to determine the firm's financial worth. Medirom Healthcare Technologies is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in price to book category among its peers fabricating about 9.01 of Price To Book per Return On Equity. At this time, Medirom Healthcare's Return On Equity is very stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Medirom Healthcare by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Medirom Price To Book vs. Return On Equity
Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Medirom Healthcare |
| = | 1.47 |
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
Medirom Healthcare |
| = | 13.24 X |
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
Medirom Price To Book Comparison
Medirom Healthcare is currently under evaluation in price to book category among its peers.
Medirom Healthcare Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Medirom Healthcare, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Medirom Healthcare will eventually generate negative long term returns. The profitability progress is the general direction of Medirom Healthcare's change in net profit over the period of time. It can combine multiple indicators of Medirom Healthcare, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Net Interest Income | -35.8 M | -34 M | |
| Interest Income | 1.1 M | 2 M | |
| Operating Income | -391.6 M | -372 M | |
| Net Income From Continuing Ops | 115 M | 120.8 M | |
| Income Before Tax | 20.6 M | 21.7 M | |
| Total Other Income Expense Net | 412.2 M | 432.8 M | |
| Net Loss | -891.7 M | -847.1 M | |
| Net Income | 115 M | 120.8 M | |
| Income Tax Expense | -94.4 M | -89.7 M | |
| Change To Netincome | 351.9 M | 369.5 M | |
| Net Income Per Share | 22.27 | 23.38 | |
| Income Quality | (5.49) | (5.22) | |
| Net Income Per E B T | 5.58 | 5.86 |
Medirom Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Medirom Healthcare. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Medirom Healthcare position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Medirom Healthcare's important profitability drivers and their relationship over time.
Use Medirom Healthcare in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Medirom Healthcare position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medirom Healthcare will appreciate offsetting losses from the drop in the long position's value.Medirom Healthcare Pair Trading
Medirom Healthcare Technologies Pair Trading Analysis
The ability to find closely correlated positions to Medirom Healthcare could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Medirom Healthcare when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Medirom Healthcare - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Medirom Healthcare Technologies to buy it.
The correlation of Medirom Healthcare is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Medirom Healthcare moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Medirom Healthcare moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Medirom Healthcare can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Medirom Healthcare position
In addition to having Medirom Healthcare in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Millennials Best Thematic Idea Now
Millennials Best
Companies or funds that provide products or services that appeal to the generation of millennials and that are expected to experience growth in the next 5 years. The millennial generation usually refers to the demographic population that were born between 1980 to 2000. The Millennials Best theme has 77 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Millennials Best Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Correlation Analysis. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
To fully project Medirom Healthcare's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Medirom Healthcare at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Medirom Healthcare's income statement, its balance sheet, and the statement of cash flows.